EVO
Price
$3.22
Change
-$0.01 (-0.31%)
Updated
Apr 3 closing price
Capitalization
2.77B
13 days until earnings call
MKGAF
Price
$138.00
Change
+$2.27 (+1.67%)
Updated
Apr 2 closing price
Capitalization
76.59B
Ad is loading...

EVO vs MKGAF

Header iconEVO vs MKGAF Comparison
Open Charts EVO vs MKGAFBanner chart's image
Evotec SE
Price$3.22
Change-$0.01 (-0.31%)
Volume$52.54K
Capitalization2.77B
Merck KGaA
Price$138.00
Change+$2.27 (+1.67%)
Volume$261
Capitalization76.59B
EVO vs MKGAF Comparison Chart
Loading...
EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVO vs. MKGAF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVO is a StrongBuy and MKGAF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (EVO: $3.23 vs. MKGAF: $141.81)
Brand notoriety: EVO and MKGAF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EVO: 67% vs. MKGAF: 14%
Market capitalization -- EVO: $2.77B vs. MKGAF: $76.59B
EVO [@Pharmaceuticals: Other] is valued at $2.77B. MKGAF’s [@Pharmaceuticals: Other] market capitalization is $76.59B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVO’s FA Score shows that 1 FA rating(s) are green whileMKGAF’s FA Score has 1 green FA rating(s).

  • EVO’s FA Score: 1 green, 4 red.
  • MKGAF’s FA Score: 1 green, 4 red.
According to our system of comparison, MKGAF is a better buy in the long-term than EVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVO’s TA Score shows that 5 TA indicator(s) are bullish.

  • EVO’s TA Score: 5 bullish, 5 bearish.

Price Growth

EVO (@Pharmaceuticals: Other) experienced а -2.71% price change this week, while MKGAF (@Pharmaceuticals: Other) price change was +2.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.02%. For the same industry, the average monthly price growth was -2.23%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

EVO is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKGAF($76.6B) has a higher market cap than EVO($2.77B). EVO has higher P/E ratio than MKGAF: EVO (476.19) vs MKGAF (20.96). MKGAF YTD gains are higher at: -6.433 vs. EVO (-22.356). MKGAF has higher annual earnings (EBITDA): 6.45B vs. EVO (-63.26M). MKGAF has more cash in the bank: 1.72B vs. EVO (619M). EVO has less debt than MKGAF: EVO (589M) vs MKGAF (10.6B). MKGAF has higher revenues than EVO: MKGAF (22.3B) vs EVO (821M).
EVOMKGAFEVO / MKGAF
Capitalization2.77B76.6B4%
EBITDA-63.26M6.45B-1%
Gain YTD-22.356-6.433348%
P/E Ratio476.1920.962,271%
Revenue821M22.3B4%
Total Cash619M1.72B36%
Total Debt589M10.6B6%
FUNDAMENTALS RATINGS
EVO vs MKGAF: Fundamental Ratings
EVO
MKGAF
OUTLOOK RATING
1..100
5020
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
9470
PRICE GROWTH RATING
1..100
8577
P/E GROWTH RATING
1..100
263
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKGAF's Valuation (29) in the null industry is significantly better than the same rating for EVO (95). This means that MKGAF’s stock grew significantly faster than EVO’s over the last 12 months.

MKGAF's Profit vs Risk Rating (83) in the null industry is in the same range as EVO (100). This means that MKGAF’s stock grew similarly to EVO’s over the last 12 months.

MKGAF's SMR Rating (70) in the null industry is in the same range as EVO (94). This means that MKGAF’s stock grew similarly to EVO’s over the last 12 months.

MKGAF's Price Growth Rating (77) in the null industry is in the same range as EVO (85). This means that MKGAF’s stock grew similarly to EVO’s over the last 12 months.

EVO's P/E Growth Rating (2) in the null industry is somewhat better than the same rating for MKGAF (63). This means that EVO’s stock grew somewhat faster than MKGAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVO
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 17 days ago
68%
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Ad is loading...
EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BLOK38.730.74
+1.95%
Amplify Transformational Data Shrg ETF
EVX36.060.47
+1.32%
VanEck Environmental Svcs ETF
RULE20.810.12
+0.58%
Adaptive Core ETF
BSJT21.170.03
+0.13%
Invesco BulletShares 2029 HY Corp Bd ETF
CGCP22.50N/A
N/A
Capital Group Core Plus Income ETF

MKGAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
+2.76%
MKKGY - MKGAF
49%
Loosely correlated
-2.16%
AQST - MKGAF
19%
Poorly correlated
-5.59%
INDV - MKGAF
17%
Poorly correlated
-1.47%
EVO - MKGAF
17%
Poorly correlated
N/A
EBS - MKGAF
16%
Poorly correlated
-6.58%
More